z-logo
open-access-imgOpen Access
Expression of p63 and Bcl-2 in Malignant Thyroid Tumors and their Correlation with other Diagnostic Immunocytochemical Markers
Author(s) -
Ashumi Gupta,
Shyama Jain,
Nita Khurana,
Arun Kakar
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/13899.8157
Subject(s) - carcinoembryonic antigen , thyroglobulin , calcitonin , pathology , thyroid carcinoma , medicine , thyroid , medullary carcinoma , anaplastic carcinoma , thyroid cancer , medullary cavity , carcinoma , immunohistochemistry , cancer
Bcl-2 is a marker recently studied in thyroid tumours and proposed to have prognostic significance. p63 is expressed in a proportion of papillary thyroid carcinoma cases and may have a role in tumour progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom